hoe 33342 and zm323881
hoe 33342 has been researched along with zm323881 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ambudkar, SV; Chen, ZS; Liu, L; Shukla, S; Wang, YJ; Xu, H; Yang, DH; Zhang, D; Zhang, GN; Zhang, XY; Zhang, YK | 1 |
Other Studies
1 other study(ies) available for hoe 33342 and zm323881
| Article | Year |
|---|---|
Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzimidazoles; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; HEK293 Cells; Humans; Mitoxantrone; Molecular Dynamics Simulation; Neoplasm Proteins; Quinazolines; Vascular Endothelial Growth Factor Receptor-2 | 2017 |